FGF23 and Marchiafava-Bignami disease: When integrating CKD-MBD management, it is vital to consider not only serum phosphate but also calcium levels, parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF23), as these biomarkers inform phosphorus targets and treatment intensity [44].